Unlock the Power of DXA Analysis in Clinical Trials
Are you looking to enhance your clinical trials with cutting-edge imaging solutions?
Our latest white paper explores how Image Analysis Group (IAG) team is support Sponsors’ trials that utilize Dual-energy X-ray Absorptiometry (DXA) to assess safety or efficacy of novel drug candidates.
Discover the Workflow and Powerful Analysis Tools in the white paper:
-
Advanced Technology: IAG utilizes its innovative Dynamika cloud platform for centralized image reading, expert oversight, and advanced analytics.
-
Comprehensive Services: From trial design to biomarker extraction, IAG supports every step of your clinical trial journey.
-
Therapeutic Focus: IAG specializes in musculoskeletal disorders, neuro-oncology, rheumatology, and immunology, helping you tackle complex diseases with precision.
-
Efficiency and Quality: Enjoy rapid study setup and high-quality data through detailed assessments and continuous monitoring of DXA image quality.
-
Advanced DXA Applications: Leverage Trabecular Bone Score (TBS) and Vertebral Fracture Assessment (VFA) for accurate insights into therapeutic efficacy and disease progression.
Download our white paper by filling in the form below to learn more about how modern AI-powered DXA analysis can transform your clinical trials.
Join the conversation and explore how IAG can help you unlock the full potential of your clinical research!